Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rowe

Showing results (711-720 of 1,019) with videos related to

Pageof 102
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 28, 2022
First-in-Humans Evaluation of <sup>18</sup>F-SMBT-1, a Novel <sup>18</sup>F-Labeled Monoamine Oxidase-B PET Tracer for Imaging Reactive AstrogliosisVictor L Villemagne, Ryuichi Harada, Vincent Doré, et al.
The Lancet. Neurology|July 25, 2016
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal studySamantha C Burnham, Pierrick Bourgeat, Vincent Doré, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 8, 2022
Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individualsKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Journal of Alzheimer'S Disease : JAD|May 28, 2017
Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older IndividualsYen Ying Lim, Robert Williamson, Simon M Laws, et al.
Neurobiology of Aging|January 15, 2015
Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of ageingRobert H Pietrzak, Yen Ying Lim, David Ames, et al.
Psychopharmacology|October 25, 2008
Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PETJ R Ellis, P J Nathan, V L Villemagne, et al.
The Lancet. Neurology|March 13, 2013
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort studyVictor L Villemagne, Samantha Burnham, Pierrick Bourgeat, et al.
Environmental Science. Processes & Impacts|February 15, 2014
Atmospheric deposition of phosphorus to land and freshwaterE Tipping, S Benham, J F Boyle, et al.
Brain : a Journal of Neurology|May 26, 2012
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal studyNicolas Villain, Gaël Chételat, Blandine Grassiot, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 17, 2016
Biotinylation: a novel posttranslational modification linking cell autonomous circadian clocks with metabolismLan He, J Austin Hamm, Alex Reddy, et al.
Pageof 102

Showing results (711-720 of 1,019) with videos related to

Sort By:
Pageof 102
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 28, 2022
First-in-Humans Evaluation of <sup>18</sup>F-SMBT-1, a Novel <sup>18</sup>F-Labeled Monoamine Oxidase-B PET Tracer for Imaging Reactive AstrogliosisVictor L Villemagne, Ryuichi Harada, Vincent Doré, et al.
The Lancet. Neurology|July 25, 2016
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal studySamantha C Burnham, Pierrick Bourgeat, Vincent Doré, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 8, 2022
Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individualsKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Journal of Alzheimer'S Disease : JAD|May 28, 2017
Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older IndividualsYen Ying Lim, Robert Williamson, Simon M Laws, et al.
Neurobiology of Aging|January 15, 2015
Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of ageingRobert H Pietrzak, Yen Ying Lim, David Ames, et al.
Psychopharmacology|October 25, 2008
Galantamine-induced improvements in cognitive function are not related to alterations in alpha(4)beta (2) nicotinic receptors in early Alzheimer's disease as measured in vivo by 2-[18F]fluoro-A-85380 PETJ R Ellis, P J Nathan, V L Villemagne, et al.
The Lancet. Neurology|March 13, 2013
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort studyVictor L Villemagne, Samantha Burnham, Pierrick Bourgeat, et al.
Environmental Science. Processes & Impacts|February 15, 2014
Atmospheric deposition of phosphorus to land and freshwaterE Tipping, S Benham, J F Boyle, et al.
Brain : a Journal of Neurology|May 26, 2012
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal studyNicolas Villain, Gaël Chételat, Blandine Grassiot, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 17, 2016
Biotinylation: a novel posttranslational modification linking cell autonomous circadian clocks with metabolismLan He, J Austin Hamm, Alex Reddy, et al.
Pageof 102